Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lama glama

ABSTRACT: Lama glama overview

PROVIDER: PRJNA421378 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	DRR222092_1.fastq.gz	Fastqsanger.gz
	DRR222092_2.fastq.gz	Fastqsanger.gz
	DRR222093_1.fastq.gz	Fastqsanger.gz
	DRR222093_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 457

Similar Datasets

Lama guanicoe

Project description:Lama guanicoe overview

| PRJNA427743 | ENA

Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq

Project description:The objective of this study is to determine changes in the global transcriptome of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH

2019-08-14 | GSE135803 | GEO

Qipengyuania citrea LAMA 915

Project description:Qipengyuania citrea LAMA 915 Genome sequencing and assembly

| PRJNA193448 | ENA

Bacillus stratosphericus LAMA 585

Project description:Bacillus stratosphericus LAMA 585 Genome sequencing and assembly

| PRJNA176166 | ENA

Marinobacter excellens LAMA 842

Project description:Marinobacter excellens LAMA 842 Genome sequencing and assembly

| PRJNA193450 | ENA

Psychrobacter nivimaris strain:LAMA 639

Project description:Psychrobacter nivimaris strain:LAMA 639 Genome sequencing and assembly

| PRJNA557251 | ENA

Lama glama chaku isolate:CD1-2017

Project description:Lama glama chaku isolate:CD1-2017 Genome sequencing and assembly

| PRJNA421373 | ENA

Lama guanicoe cacsilensis isolate:CD2-2017

Project description:Lama guanicoe cacsilensis isolate:CD2-2017 Genome sequencing and assembly

| PRJNA427644 | ENA

Lama glama

Project description:VHH screening

| PRJDB7510 | ENA

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA.

Project description:BackgroundCurrent pharmacological therapies for COPD improve quality of life and symptoms and reduce exacerbations. Given the progressive nature of COPD, it is arguably more important to understand whether the available therapies are able to delay clinical deterioration; the concept of "clinically important deterioration" (CID) has therefore been developed. We evaluated the efficacy of the single-inhaler triple combination beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G), using data from three large 1-year studies.MethodsThe studies compared BDP/FF/G to BDP/FF (TRILOGY), tiotropium (TRINITY), and indacaterol/glycopyrronium (IND/GLY; TRIBUTE). All studies recruited patients with symptomatic COPD, FEV1 <50%, and an exacerbation history. We measured the time to first CID and to sustained CID, an endpoint combining FEV1, St George's Respiratory Questionnaire (SGRQ), moderate-to-severe exacerbations, and death. The time to first CID was based on the first occurrence of any of the following: a decrease of ≥100 mL from baseline in FEV1, an increase of ≥4 units from baseline in SGRQ total score, the occurrence of a moderate/severe COPD exacerbation, or death. The time to sustained CID was defined as: a CID in FEV1 and/or SGRQ total score maintained at all subsequent visits, an exacerbation, or death.ResultsExtrafine BDP/FF/G significantly extended the time to first CID vs BDP/FF (HR 0.61, P<0.001), tiotropium (0.72, P<0.001), and IND/GLY (0.82, P<0.001), and significantly extended the time to sustained CID vs BDP/FF (HR 0.64, P<0.001) and tiotropium (0.80, P<0.001), with a numerical extension vs IND/GLY.ConclusionIn patients with symptomatic COPD, FEV1 <50%, and an exacerbation history, extrafine BDP/FF/G delayed disease deterioration compared with BDP/FF, tiotropium, and IND/GLY.Trial registrationThe studies are registered in ClinicalTrials.gov: TRILOGY, NCT01917331; TRINITY, NCT01911364; TRIBUTE, NCT02579850.

| S-EPMC6400232 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data